Ghimas Fisiograft Nano HA Reinforced - Bone Regeneration Material - 2x1ml

En stock - 100 articles disponibles
Unité de gestion de stock: PFOF0040
Prix $135.00 inc. T.V.A.
Vous pouvez nous contacter pour vos commandes et questions. +90543 456 2614
Toutes vos commandes sont envoyées par fret aérien rapide avec UPS EXPRESS Shipping
Vos commandes seront préparées et expédiées sous 3 jours ouvrés.
Le dédouanement dans votre pays n'est pas à la charge du vendeur.

Fisiograft Nano H.A.

  • Consists of granules placed in a syringe, enabling direct application to the bone defect.
  • Granules are produced from a nanohydroxyapatite and polylactic-polylglycolic copolymer composite material.
  • These components have been used for years in space maintainers for guided bone tissue regeneration.
  • It permeates with blood from host tissue and, thanks to the presence of hydroxyapatite, becomes a support for ossification of new bone tissue at the application site.

FISIOGRAFT nano-H.A. reinforced

  • Consists of granules placed in a syringe, enabling direct application to the bone defect.
  • Granules are produced from a nanohydroxyapatite-dextran composite material with a polylactic-polylglycolic copolymer mixture used as carrier.
  • Components have been used for years in space maintainers for guided bone tissue regeneration.
  • It permeates with blood from bone and, thanks to the presence of nanometric hydroxyapatite, becomes a nucleus for ossification of new bone tissue at the application site.

OSSEOINTEGRATION IN 6–9 MONTHS

  • Composition: Hydroxyapatite 47% (470 mg), PLGA 5% (50 mg), Dextran 18% (180 mg), PEG 30% (300 mg)
  • Granule size: 70><100 nm
  • Packaging: 2x1ml syringe

HYDROXYAPATITE

  • Patented manufacturing process
  • Characteristics that mimic the structural, dimensional and biofunctional properties of natural hydroxyapatite found in dentin, cementum and bone
  • Non-resorbable structure that provides osseointegration
  • Less inflammatory than normal hydroxyapatite
  • Leads to increased production of bone alkaline phosphatase and osteocalcin, indicating increased bone production

READY TO USE

  • Histomorphometric analysis shows 42% newly formed bone, 21% nano-hydroxyapatite, and 37% medullary spaces.
  • This result was obtained with FISIOGRAFT NANO HA REINFORCED just four months after surgery.
  • This value is comparable to results obtained with autologous bone or other space maintainers after 6–8 months as stated in the literature (2, 3).

ADVANTAGES OF FISIOGRAFT NANO HA REINFORCED

  • RESORPTION + OSSEOINTEGRATION
  • PLGA degradation within 3–6 months to make room for newly formed bone
  • Hydroxyapatite integrates with the mineralized structure of bone
  • NO RISK: BSE – HIV – HBV – SARS
  • High biocompatibility
  • Easy application